Status
Conditions
Treatments
About
The trial will examine whether a centralized Prevention Health & Cardiovascular Risk Service (PHCVRS) run by clinical pharmacists at the University of Iowa can be implemented in primary care offices and whether it can improve the care delivered to patients at risk for developing cardiovascular disease.
Full description
The use of clinical pharmacists in primary care has improved the control of several chronic cardiovascular conditions. However, many private physician practices lack the resources to implement team-based care with pharmacists. The purpose of this study was to evaluate whether a centralized, remote, clinical pharmacy service could improve guideline adherence and secondary measures of cardiovascular risk in primary care offices in rural and small communities.
This study was a prospective trial in 12 family medicine offices cluster randomized to either the intervention or usual care. The intervention was delivered for 12 months, and subjects had research visits at baseline and 12 months. The primary outcome was adherence to guidelines, and secondary outcomes included changes in key cardiovascular risk factors and preventative health measures. We enrolled 302 subjects.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
INCLUSION CRITERIA
Section A: Demographic Criteria
Patient was seen in your clinic or practice at least once in the past 24 months
English-speaking male or female
Age is 50 or older at medical record screening
Section B: Risk Factors - Must have at least one of the following conditions
Uncontrolled diabetes (Hemoglobin A1c > or + 7.5)
Elevated LDL cholesterol > 110 for patients with PAD, CAD, stroke or diabetes or > 140 otherwise
Elevated blood pressure with:
Section C: Cardiovascular Conditions - total number of risk factors in Section B (above) plus number of conditions Section C (below) must be THREE OR MORE
History of coronary artery disease
Previous Heart Attack
History of Stroke
History of Transient Ischemic Attack
History of Atrial fibrillation
History of Peripheral Vascular Disease / claudication
History of carotid artery disease
Current smoker
Obesity with BMI > 30
EXCLUSION CRITERIA
Section D: Exclusion Criteria - has NONE of the following:
Inability to give informed consent
Pregnant
Diagnosis of pulmonary hypertension (Note: secondary pulmonary hypertension is OK)
Cancer diagnosis with a life expectancy estimated less than 2 years
Residence in a nursing home or diagnosis of dementia
No telephone or a hearing impairment not allowing them to use a phone
Refusal to consider attempting to use the internet at home, community center, library, medical office or other source to access the PHRM
Patient has plans to move from the area or transfer care to a different clinic in the next 12 months
Omron blood pressure cuff cannot be used on patient's arm for any reason
Primary purpose
Allocation
Interventional model
Masking
302 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal